ASHG 2019
Recent articles
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Antidote to ‘poison’ DNA may treat lethal form of epilepsy
An experimental drug silences a DNA segment and seems to prevent seizures and death in a condition related to autism.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Brain ‘organoids’ point to new drug target for fragile X syndrome
New findings hint at why drugs that work in mouse models of fragile X syndrome have not been effective in people.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Massive project doubles list of genes tied to autism
The largest analysis of sequences from autistic people and their families implicates 184 genes in the condition — nearly doubling the previous estimate.
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.